HF Patients With LVADs Being Treated With SGLT2i
NCT05278962
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DRUG:
SGLT2i
OTHER:
No SGLT2i
Sponsor
University of Chicago